Navigation Links
Reportlinker Adds Biomarkers - Technologies, Markets and Companies
Date:6/3/2010

resistance against HIV 106

Complications of AIDS 106

AIDS and the nervous system 106

Opportunistic infections in AIDS 107

Coexistent HIV-1 and HSV-2 107

Coexistent hepatitis virus infections with HIV 108

HIV and HBV 108

HIV and HCV 108

AIDS wasting syndrome 109

Current therapies 109

Aim of anti-HIV drugs 111

Efavirenz 111

Tipranavir 112

Enfuvirtide 112

Darunavir 112

Impact of antiretroviral treatment on transmission of HIV 113

Postexposure prophylaxis against HIV 114

Limitations of current therapies 114

Adverse effects of antiretroviral therapy 114

Drug resistance in AIDS 115

Effect of interruption of HIV treatment 116

Reservoirs of HIV Infection 116

Persistance of low-level viremia in HIV-1 patients on retroviral therapy 116

Reconsideration of abandoned therapies for AIDS 116

Therapies in development 117

Drugs in development for HIV/AIDS 117

Nucleoside reverse transcriptase inhibitors 118

Apricitabine 118

Non-nucleoside reverse transcriptase inhibitors 118

Etravirine 118

IDX899 118

Novel pro
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. Reportlinker Adds Future of Red Biotechnology in China
2. Reportlinker Adds The Future of Nutrigenomics: New opportunities in personalized nutrition and food-pharma collaboration
3. Reportlinker Adds the Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
4. Reportlinker Adds SNP Genotyping and Analysis Markets
5. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
6. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
7. Reportlinker Adds Biotechnology Instrumentation - International Market Trends
8. Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective
9. Reportlinker Adds Pharmacodynamic Assays
10. Reportlinker Adds Neurostimulation - A Global Market Perspective
11. Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 The empty capsules market ... ageing population and technological innovations in the empty ... are catalysing the growth of the empty capsules ... , Scope of Report , The report ... new entrants/smaller firms to gauge the pulse of ...
(Date:12/19/2014)... YORK , Dec. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced the ... today. "This was a transformational year in ... promising future for our company," said Sergio Traversa ... year, we have executed on key financial, human resource ...
(Date:12/17/2014)... BASKING RIDGE, N.J. (PRWEB) December 17, 2014 ... Ipsen (Euronext: IPN; ADR: IPSEY), ... 120 mg (referred to as Somatuline®) was approved ... for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) ... differentiated, locally advanced or metastatic disease to improve ...
(Date:12/17/2014)... December 17, 2014 Audacity, a leading ... and member of the Huntsworth Health Group, is proud ... executive team. In her role, Gonzales will serve as ... are incredibly honored to welcome a talent of Jamie’s ... CEO, Gaëtan Fraikin. “She is a proven healthcare innovation ...
Breaking Biology Technology:Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
... MADISON, N.J., April 15 Quest Diagnostics,Incorporated (NYSE: ... resolution of the,previously disclosed federal government investigation related ... kit manufacturing subsidiary closed,voluntarily in 2006. Quest Diagnostics ... 2004. , Quest Diagnostics ...
... Center for Career and Technical Education (NRCCTE), funded by the Office ... recently published a report that focuses on the question: What Will ... of research that centered on three questions: , , ... degree can secondary and postsecondary instruction be articulated? , ...
... April 15 deCODE genetics,(Nasdaq: DCGN ) today ... the,execution of strategic alternatives currently under consideration, it has,elected ... April 15 interest,payment on its outstanding 3.5% Senior Convertible ... deCODE , deCODE is a ...
Cached Biology Technology:Quest Diagnostics Finalizes Previously Announced Settlement With Government Related to Test Kit Subsidiary Closed in 2006 2What Will Be the Impact of Programs of Study? 2deCODE to Utilize Grace Period for Interest Payment on Senior Convertible Notes 2
(Date:12/19/2014)... Dec. 18, 2014 Research and Markets ... of the "iPhone 5S Fingerprint Sensor - ... report to their offering. ... of AuthenTec in July 2012, Apple introduced the ... is currently the only device of Apple incorporating ...
(Date:12/19/2014)... DUBLIN , Dec. 18, 2014 Research and ... addition of the "Micro Market Monitor: North America ... http://photos.prnewswire.com/prnh/20130307/600769 ... grow at a CAGR of 3.6% from 2014 to ... in this market, Canada is ...
(Date:12/19/2014)... MOUNTAIN VIEW, Calif. , Dec. 18, 2014 /PRNewswire/ ... the publication of a study that pinpoints fine-scale differences ... the United States . Since immigrants ... the United States has served as ... study illuminates how American history and the ongoing mixing ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 323andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4
... NEW YORK, April 2, 2010 The television ... it comes to communicating realistic and helpful information about ... media panel assembled today at Pace University in New ... and Strategies to Overcome and Prevent (STOP) Obesity Alliance ...
... , , , , , , ... , , , ... and points to potential pathogens much faster than what humans can accomplish. Hence, the diseases... , ... , , , , , ...
... diabetes, and fibromyalgia have in common? The answer is ... this essential vitamin and as a result suffer from ... life-threatening illnesses. In the landmark book THE VITAMIN D ... Health Problem (Penguin/Hudson Street Press; April 1, 2010) Dr. ...
Cached Biology News:Eating disorders, obesity and communications experts tackle 'weighty matters' 2New technology enables machines to detect microscopic pathogens in water 2New technology enables machines to detect microscopic pathogens in water 3New technology enables machines to detect microscopic pathogens in water 4'The Vitamin D Solution' 2
... is designed to stabilize the biomolecules ... storage. There are neither animal ... is a convenient 10 times solution ... superior to other traditional lyophilizing additives ...
... is Tecans open platform for clinical diagnostic ... and performance in the clinical diagnostic and ... flexible barcode reading and sample traceability as ... system complies with the IVD-Directive* established in ...
... flexible on your protocols, easy on your budget. ... sample throughput instrument at a highly affordable price. ... The truly user-friendly fully interchangeable block system allows ... seconds without the need of any tools (60 ...
Preparation Note: Prepared by method of Wimmer, E., et al., Biochemistry, 7, 2623 (1968). Quality Clarifier: Acceptor Activity: approx. 1000 picomoles phenylalanine per A 260 unit (not determined b...
Biology Products: